Innovative Solutions Reports Strong Q4 Earnings Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 28 2026
0mins
Should l Buy ISSC?
Source: Businesswire
Innovative Solutions and Support Inc's stock surged by 28.30% as it crossed above the 5-day SMA, reflecting strong market interest following its recent earnings report.
The company's Q4 financial performance showed a GAAP EPS of $0.39 and revenue of $22.2 million, marking a 44.3% year-over-year increase. This impressive growth is attributed to the company's strategic rebranding as Innovative Aerosystems and strong market positioning within the aerospace sector. The stock's remarkable 90% increase indicates significant investor confidence and potential for further gains.
This strong performance not only highlights the company's operational success but also suggests a positive outlook for future growth, especially with the upcoming Q3 earnings announcement expected to further bolster investor interest.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ISSC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ISSC
Wall Street analysts forecast ISSC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ISSC is 17.50 USD with a low forecast of 17.50 USD and a high forecast of 17.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 18.030
Low
17.50
Averages
17.50
High
17.50
Current: 18.030
Low
17.50
Averages
17.50
High
17.50
About ISSC
Innovative Solutions and Support, Inc. specializes in the engineering, manufacturing, and supply of advanced avionic solutions. The Company's global product reach and customer base span commercial, business and aviation and military markets, catering to both airframe manufacturers and aftermarket services for fixed-wing and rotorcraft applications. Its product portfolio consists of five categories: integrated flight deck systems COCKPIT/IP, navigation systems, communication systems, sensors and control systems, and advanced flight actuators. Its integrated flight deck systems COCKPIT/IP category includes crew alerting and engine displays, integrated standby instruments and mission displays. Its navigation systems category includes flight management systems, navigation radios and transponders. Its communication systems category includes communication radios, audio panels and radio management units. Its sensors and control systems category includes air data computers and magnetometers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Innovative Aerosystems to Release Q1 2026 Results and Host Conference Call
- Earnings Release Schedule: Innovative Aerosystems is set to announce its Q1 2026 financial results before the market opens on February 12, 2026, reflecting the company's commitment to transparency and investor communication.
- Conference Call Details: A conference call will be held the same day at 10:00 AM ET to discuss financial results and recent events, providing an opportunity for investor interaction with management and enhancing investor confidence.
- Webcast Availability: The company will offer a webcast of the conference call and accompanying materials on its website, ensuring timely information access for investors and improving information dissemination efficiency.
- Company Background: Innovative Aerosystems specializes in the engineering, manufacturing, and supply of advanced avionic solutions, leveraging a robust patent portfolio and high aircraft certification standards to meet the aerospace industry's demand for sophisticated technology products.
See More
Teledyne Technologies TDY: Leading Aerospace Player with Nearly 10% Growth Outlook Over Next 3-5 Years
- Teledyne's Strong Performance: Teledyne Technologies operates in defense and aerospace, covering advanced instrumentation and defense systems, showcasing a durable competitive position with recurring demand, and is expected to achieve nearly 10% growth annually over the next 3-5 years.
- AAR Hits Record Highs: AAR provides aviation services to commercial and defense clients, with demand significantly increasing due to rising global defense activities, leading to the stock reaching all-time highs at the start of the year, supported by an 11% rise in current quarter earnings estimates over the past 30 days.
- Innovative Solutions' Huge Potential: Innovative Solutions and Support focuses on avionics for military and commercial aircraft, with current quarter earnings estimates surging 233% in the last 60 days, indicating a sharp improvement in business conditions, positioning it as a potential leader among small-cap defense stocks.
- Investors Should Consider Defense Stocks: Amid escalating geopolitical uncertainty, defense and aerospace stocks offer stability and growth opportunities, with Teledyne, AAR, and Innovative Solutions demonstrating strong fundamentals and technicals, making them suitable for investors seeking long-term growth.
See More
Teledyne Technologies (TDY) Shows Strong Defense Performance with Nearly 10% Growth Outlook Over Next 3-5 Years
- Defense Spending Surge: As governments reassess security priorities and increase defense budgets, Teledyne Technologies (TDY) benefits from this trend, with an expected growth rate of nearly 10% over the next 3-5 years, further solidifying its market leadership.
- Strong Financial Performance: Teledyne's stock trades at approximately 24.4x forward earnings, slightly above the market average, but this valuation is supported by stable cash flows and consistent execution, highlighting the company's competitive advantage in the industry.
- AAR's Market Momentum: AAR Corp. (AIR) excels in aviation services and logistics solutions, with current quarter earnings estimates rising 11% over the past 30 days, and sales expected to grow by 15.2%, indicating significantly increased demand amid rising defense activities.
- ISSC's Growth Potential: Innovative Solutions and Support, Inc. (ISSC) has seen its current quarter earnings estimates surge by 233% over the past 60 days, reflecting strong growth potential in the defense and aerospace sector, and despite higher volatility, its technical breakthroughs may position it as a leader among small-cap defense stocks.
See More
TG Therapeutics Reports $616 Million Revenue for FY 2025, Shares Surge 11.6%
- Strong Financial Performance: TG Therapeutics reported preliminary total global revenue of approximately $616 million for FY 2025, with Q4 U.S. net product revenue for BRIUMVI at about $182 million, indicating robust market performance that is expected to boost shareholder confidence.
- Significant Stock Surge: Following the earnings report, TG Therapeutics shares jumped 11.6% to $31.10 on Wednesday, reflecting investor optimism about the company's growth potential, which may attract more capital inflow.
- Positive Market Reaction: Despite a broader market decline with the Nasdaq Composite falling over 200 points, TG Therapeutics' strong financial data allowed it to stand out among numerous stocks, showcasing its competitiveness in the biopharmaceutical sector.
- Optimistic Future Outlook: Although the financial figures are unaudited, the preliminary results suggest that the company is poised for continued growth, particularly in the marketing of its BRIUMVI product, which could further enhance its market share.
See More
CurtissWright Authorizes $416 Million for Stock Buyback Program
- Stock Buyback Program: CurtissWright authorized an additional $416 million for stock repurchases in November 2025, raising the total authorization to $550 million, which underscores the company's financial strength and boosts shareholder confidence.
- Sales Growth Outlook: The Zacks Consensus Estimate indicates a 6.9% year-over-year sales growth for CurtissWright in 2026, with earnings expected to rise by 11.6%, reflecting strong performance in the aerospace-defense market.
- Industry M&A Trends: The aerospace-defense sector is leveraging mergers and acquisitions to enhance operational scale and market presence, exemplified by AAR's $78 million acquisition of HAECO Americas, which strengthens its maintenance capabilities and drives long-term growth.
- Global Air Traffic Growth: According to the International Air Transport Association, global air passenger traffic increased by 5.3% year-over-year, providing airlines with robust market demand for replacement parts despite ongoing supply chain challenges.
See More
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
- Capital Raising Announcement: Intelligent Bio Solutions revealed plans to raise $10 million through a private placement, which led to a sharp 19.7% decline in its stock price during Friday's session, indicating a negative impact on investor confidence and market performance.
- Stock Price Reaction: Following the announcement, shares of Intelligent Bio fell to $7.65, reflecting market concerns regarding the company's future financial health and potentially affecting its ability to secure further funding.
- Market Dynamics: While Intelligent Bio's stock plummeted, other stocks such as Lavoro Limited and Ironwood Pharmaceuticals surged by 181% and 57.7% respectively, highlighting a divergence in market performance among different companies.
- Investor Focus: The announcement of this capital raising plan may prompt investors to reassess Intelligent Bio's strategic direction, particularly in the current market environment where the necessity and timing of fundraising are critically important.
See More
Innovative Aerosystems to Release Q1 2026 Results and Host Conference Call
- Earnings Release Schedule: Innovative Aerosystems is set to announce its Q1 2026 financial results before the market opens on February 12, 2026, reflecting the company's commitment to transparency and investor communication.
- Conference Call Details: A conference call will be held the same day at 10:00 AM ET to discuss financial results and recent events, providing an opportunity for investor interaction with management and enhancing investor confidence.
- Webcast Availability: The company will offer a webcast of the conference call and accompanying materials on its website, ensuring timely information access for investors and improving information dissemination efficiency.
- Company Background: Innovative Aerosystems specializes in the engineering, manufacturing, and supply of advanced avionic solutions, leveraging a robust patent portfolio and high aircraft certification standards to meet the aerospace industry's demand for sophisticated technology products.
See More
Teledyne Technologies TDY: Leading Aerospace Player with Nearly 10% Growth Outlook Over Next 3-5 Years
- Teledyne's Strong Performance: Teledyne Technologies operates in defense and aerospace, covering advanced instrumentation and defense systems, showcasing a durable competitive position with recurring demand, and is expected to achieve nearly 10% growth annually over the next 3-5 years.
- AAR Hits Record Highs: AAR provides aviation services to commercial and defense clients, with demand significantly increasing due to rising global defense activities, leading to the stock reaching all-time highs at the start of the year, supported by an 11% rise in current quarter earnings estimates over the past 30 days.
- Innovative Solutions' Huge Potential: Innovative Solutions and Support focuses on avionics for military and commercial aircraft, with current quarter earnings estimates surging 233% in the last 60 days, indicating a sharp improvement in business conditions, positioning it as a potential leader among small-cap defense stocks.
- Investors Should Consider Defense Stocks: Amid escalating geopolitical uncertainty, defense and aerospace stocks offer stability and growth opportunities, with Teledyne, AAR, and Innovative Solutions demonstrating strong fundamentals and technicals, making them suitable for investors seeking long-term growth.
See More
Teledyne Technologies (TDY) Shows Strong Defense Performance with Nearly 10% Growth Outlook Over Next 3-5 Years
- Defense Spending Surge: As governments reassess security priorities and increase defense budgets, Teledyne Technologies (TDY) benefits from this trend, with an expected growth rate of nearly 10% over the next 3-5 years, further solidifying its market leadership.
- Strong Financial Performance: Teledyne's stock trades at approximately 24.4x forward earnings, slightly above the market average, but this valuation is supported by stable cash flows and consistent execution, highlighting the company's competitive advantage in the industry.
- AAR's Market Momentum: AAR Corp. (AIR) excels in aviation services and logistics solutions, with current quarter earnings estimates rising 11% over the past 30 days, and sales expected to grow by 15.2%, indicating significantly increased demand amid rising defense activities.
- ISSC's Growth Potential: Innovative Solutions and Support, Inc. (ISSC) has seen its current quarter earnings estimates surge by 233% over the past 60 days, reflecting strong growth potential in the defense and aerospace sector, and despite higher volatility, its technical breakthroughs may position it as a leader among small-cap defense stocks.
See More
TG Therapeutics Reports $616 Million Revenue for FY 2025, Shares Surge 11.6%
- Strong Financial Performance: TG Therapeutics reported preliminary total global revenue of approximately $616 million for FY 2025, with Q4 U.S. net product revenue for BRIUMVI at about $182 million, indicating robust market performance that is expected to boost shareholder confidence.
- Significant Stock Surge: Following the earnings report, TG Therapeutics shares jumped 11.6% to $31.10 on Wednesday, reflecting investor optimism about the company's growth potential, which may attract more capital inflow.
- Positive Market Reaction: Despite a broader market decline with the Nasdaq Composite falling over 200 points, TG Therapeutics' strong financial data allowed it to stand out among numerous stocks, showcasing its competitiveness in the biopharmaceutical sector.
- Optimistic Future Outlook: Although the financial figures are unaudited, the preliminary results suggest that the company is poised for continued growth, particularly in the marketing of its BRIUMVI product, which could further enhance its market share.
See More
CurtissWright Authorizes $416 Million for Stock Buyback Program
- Stock Buyback Program: CurtissWright authorized an additional $416 million for stock repurchases in November 2025, raising the total authorization to $550 million, which underscores the company's financial strength and boosts shareholder confidence.
- Sales Growth Outlook: The Zacks Consensus Estimate indicates a 6.9% year-over-year sales growth for CurtissWright in 2026, with earnings expected to rise by 11.6%, reflecting strong performance in the aerospace-defense market.
- Industry M&A Trends: The aerospace-defense sector is leveraging mergers and acquisitions to enhance operational scale and market presence, exemplified by AAR's $78 million acquisition of HAECO Americas, which strengthens its maintenance capabilities and drives long-term growth.
- Global Air Traffic Growth: According to the International Air Transport Association, global air passenger traffic increased by 5.3% year-over-year, providing airlines with robust market demand for replacement parts despite ongoing supply chain challenges.
See More
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
- Capital Raising Announcement: Intelligent Bio Solutions revealed plans to raise $10 million through a private placement, which led to a sharp 19.7% decline in its stock price during Friday's session, indicating a negative impact on investor confidence and market performance.
- Stock Price Reaction: Following the announcement, shares of Intelligent Bio fell to $7.65, reflecting market concerns regarding the company's future financial health and potentially affecting its ability to secure further funding.
- Market Dynamics: While Intelligent Bio's stock plummeted, other stocks such as Lavoro Limited and Ironwood Pharmaceuticals surged by 181% and 57.7% respectively, highlighting a divergence in market performance among different companies.
- Investor Focus: The announcement of this capital raising plan may prompt investors to reassess Intelligent Bio's strategic direction, particularly in the current market environment where the necessity and timing of fundraising are critically important.
See More
